SPEN

protein-coding

spen family transcriptional repressor, the group of RNA binding motif containing

Gene summary

This gene encodes a hormone inducible transcriptional repressor. Repression of transcription by this gene product can occur through interactions with other repressors, by the recruitment of proteins involved in histone deacetylation, or through sequestration of transcriptional activators. The product of this gene contains a carboxy-terminal domain that permits binding to other corepressor proteins. This domain also permits interaction with members of the NuRD complex, a nucleosome remodeling protein complex that contains deacetylase activity. In addition, this repressor contains several RNA recognition motifs that confer binding to a steroid receptor RNA coactivator; this binding can modulate the activity of both liganded and nonliganded steroid receptors. [provided by RefSeq, Jul 2008]

MANE transcript

NM_015001.3

Inheritance

AD

ClinVar variants

P:119U:650B:281

Top phenotype

Radio-Tartaglia syndrome

gnomAD constraint

pLI —, LoF o/e 0.03

Max pathogenic AF

—

Genomic locus

chr1:15,836,095-15,940,456

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~104.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Radio-Tartaglia syndromeDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0859143

Submitter: ClinGen

The SPEN gene is located on chromosome 1 at 1p36.21-p36.13 and appears to function as a nuclear matrix platform that organizes and integrates transcriptional responses, and is thought to be involved in chromatin remodeling. SPEN was first reported in relation to autosomal dominant SPEN-related neurodevelopmental disorder in 2021 by Radio et al. (PMID: 33596411). The clinical profile of this disease includes developmental delay/intellectual disability, autism spectrum disorder, behavioral abnormalities, hypotonia, brain and spine anomalies, congenital heart defects, gait imbalance, variable facial dysmorphisms, and obesity/increased BMI, especially in females. This curation included 7 unique truncating variants (4 nonsense and 3 frameshift) in 7 probands from 1 publication (PMID: 33596411). The majority of cases showed de novo inheritance, but familial inheritance in one family was scored. Note there are additional unpublished cases. The maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. This gene-disease relationship is also supported by experimental evidence including expression in the developing human neocortex and several animal models (Drosophila and conditional knockout mouse) in which inactivation of SPEN was associated with a neuronal phenotype (PMIDs: 10704397, 17457934). In summary, there is definitive evidence supporting the relationship between SPEN and autosomal dominant SPEN-related neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders Gene Curation Expert Panel on the meeting date 11/01/2023.

Radio-Tartaglia syndromeSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0859143

Submitter: PanelApp Australia

Radio-Tartaglia syndromeSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0859143

Submitter: Labcorp Genetics (formerly Invitae)

complex neurodevelopmental disorderNO_KNOWN

Inheritance Pattern: AD

Disease ID:MONDO:0100038

Submitter: Illumina

Radio-Tartaglia syndromeDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0859143

Submitter: G2P

Clinical Genomic Database (CGD)

Radio-Tartaglia syndromeAD

Manifestation: Cardiovascular; Craniofacial; Endocrine; Musculoskeletal; Neurologic

Intervention: Cardiovascular

Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early management

Refs: 33596411Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SPEN variants in ClinVar

16 Conditions Cataloged
not providedTotal: 437
Inborn genetic diseasesTotal: 411
SPEN-related disorderTotal: 148
Radio-Tartaglia syndromeTotal: 129
not specifiedTotal: 84
See casesTotal: 5
Autism spectrum disorderTotal: 4
Neurodevelopmental delayTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_015001.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
6
clinvar
126
clinvar
6
clinvar
138
missense
1
clinvar
629
clinvar
133
clinvar
16
clinvar
779
nonsense
24
clinvar
22
clinvar
6
clinvar
52
start loss
0
frameshift
41
clinvar
30
clinvar
3
clinvar
74
splice donor/acceptor (+/-2bp)
1
clinvar
6
clinvar
7
Total6752650259221050

Highest pathogenic variant AF is 0.0000065733257

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 11 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_015001.3RefSeqNP_055816.215MANE Select
ENST00000375759.8EnsemblENSP00000364912.315MANE Select
ENST00000438066.2EnsemblENSP00000388021.22Standard
ENST00000442985.1EnsemblENSP00000400914.17Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Notch Signaling Pathway
  • Notch
  • Notch
  • Notch signaling pathway
  • Notch-mediated HES/HEY network

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • Notch signaling pathway
  • viral process
  • negative regulation of transcription, DNA-templated
  • positive regulation of neurogenesis

Molecular Function

  • RNA polymerase II transcription factor binding
  • DNA binding
  • transcription corepressor activity
  • RNA binding
  • protein binding

Cellular Component

  • nucleus
  • nucleoplasm
  • transcriptional repressor complex
  • extracellular exosome

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000375759
Coding exons
15
Length
92597
Individuals with no LoFs
125730
Homozygous LoFs
0
Heterozygous LoFs
18
Defined
125748
p
0.0000716
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.8916972.07e+30.8210.00012423759
Missense (PolyPhen)659975.570.675511054
Synonymous-0.3238228101.010.00005017710
Loss of Function10.241290.03100.000008721443

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000620.000062rare
Latino/Admixed American0.0000580.000058rare
Ashkenazi Jewish0.0000990.000099rare
East Asian0.0000540.000054rare
Finnish0.000190.00018rare
European (Non-Finnish)0.0000880.000079rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: May serve as a nuclear matrix platform that organizes and integrates transcriptional responses. In osteoblasts, supports transcription activation: synergizes with RUNX2 to enhance FGFR2- mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Has also been shown to be an essential corepressor protein, which probably regulates different key pathways such as the Notch pathway. Negative regulator of the Notch pathway via its interaction with RBPSUH, which prevents the association between NOTCH1 and RBPSUH, and therefore suppresses the transactivation activity of Notch signaling. Blocks the differentiation of precursor B-cells into marginal zone B-cells. Probably represses transcription via the recruitment of large complexes containing histone deacetylase proteins. May bind both to DNA and RNA. {ECO:0000250, ECO:0000269|PubMed:11331609, ECO:0000269|PubMed:12374742}.;

Recessive Scores

pRec
0.160

Intolerance Scores

LoFtool
0.206
RVIS EVS
-2.31
RVIS percentile EVS
1.21

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
N
Essential (gene trap)
K
Indispensability pred.
E
Indispensability score
0.859

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.